2006 Kansas Code - 39-7,120

      39-7,120.   Limitations on restrictions of patient access to prescription-only drugs through prior authorization or restrictive formulary; rules and regulations; factors to consider. [See Revisor's Note] (a) The director of health policy and finance shall not restrict patient access to prescription-only drugs pursuant to a program of prior authorization or a restrictive formulary except by rules and regulations adopted in accordance with K.S.A. 77-415 et seq., and amendments thereto. Prior to the promulgation of any such rules and regulations, the director of health policy and finance shall submit such proposed rules and regulations to the medicaid drug utilization review board for written comment. The director [of] health policy and finance may not implement permanent prior authorization until 30 days after receipt of comments by the drug utilization review board.

      (b)   When considering recommendations from the medicaid drug utilization review board regarding the prior authorization of a drug, the director of health policy and finance shall consider the net economic impact of such prior authorization, including, but not limited to, the costs of specific drugs, rebates or discounts pursuant to 42 U.S.C. 1396r-8, dispensing costs, dosing requirements and utilization of other drugs or other medicaid health care services which may be related to the prior authorization of such drug.

      History:   L. 1994, ch. 254, § 4; L. 2002, ch. 180, § 8; L. 2005, ch. 187, § 25; July 1.